Literature DB >> 21807799

OARSI/OMERACT initiative to define states of severity and indication for joint replacement in hip and knee osteoarthritis. An OMERACT 10 Special Interest Group.

Laure Gossec1, Simon Paternotte, Clifton O Bingham, Daniel O Clegg, Philippe Coste, Philip G Conaghan, Aileen M Davis, Giampaolo Giacovelli, Klaus-Peter Gunther, Gillian Hawker, Marc C Hochberg, Joanne M Jordan, Jeffrey N Katz, Margreet Kloppenburg, Arturo Lanzarotti, Keith Lim, L Stefan Lohmander, Nizar N Mahomed, Jean Francis Maillefert, Rebecca L Manno, Lyn M March, Steven A Mazzuca, Karel Pavelka, Leonardo Punzi, Ewa M Roos, Lucio C Rovati, Helen Shi, Jasvinder A Singh, Maria E Suarez-Almazor, Eleonora Tajana-Messi, Maxime Dougados.   

Abstract

OBJECTIVE: To define pain and physical function cutpoints that would, coupled with structural severity, define a surrogate measure of "need for joint replacement surgery," for use as an outcome measure for potential structure-modifying interventions for osteoarthritis (OA).
METHODS: New scores were developed for pain and physical function in knee and hip OA. A cross-sectional international study in 1909 patients was conducted to define data-driven cutpoints corresponding to the orthopedic surgeons' indication for joint replacement. A post hoc analysis of 8 randomized clinical trials (1379 patients) evaluated the prevalence and validity of cutpoints, among patients with symptomatic hip/knee OA.
RESULTS: In the international cross-sectional study, there was substantial overlap in symptom levels between patients with and patients without indication for joint replacement; indeed, it was not possible to determine cutpoints for pain and function defining this indication. The post hoc analysis of trial data showed that the prevalence of cases that combined radiological progression, high level of pain, and high degree of function impairment was low (2%-12%). The most discriminatory cutpoint to define an indication for joint replacement was found to be [pain (0-100) + physical function (0-100) > 80].
CONCLUSION: These results do not support a specific level of pain or function that defines an indication for joint replacement. However, a tentative cutpoint for pain and physical function levels is proposed for further evaluation. Potentially, this symptom level, coupled with radiographic progression, could be used to define "nonresponders" to disease-modifying drugs in OA clinical trials.

Entities:  

Mesh:

Year:  2011        PMID: 21807799      PMCID: PMC3260473          DOI: 10.3899/jrheum.110403

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  23 in total

1.  Concomitant therapy: an outcome variable for musculoskeletal disorders? Part 2: total joint replacement in osteoarthritis trials.

Authors:  Jean-Francis Maillefert; Gillian A Hawker; Laure Gossec; Nizar N Mahomed; Stefan Lohmander; Paul A Dieppe; Gustavo Zanoli; Marc C Hochberg; Maxime Dougados
Journal:  J Rheumatol       Date:  2005-12       Impact factor: 4.666

2.  Development and preliminary psychometric testing of a new OA pain measure--an OARSI/OMERACT initiative.

Authors:  G A Hawker; A M Davis; M R French; J Cibere; J M Jordan; L March; M Suarez-Almazor; J N Katz; P Dieppe
Journal:  Osteoarthritis Cartilage       Date:  2008-04       Impact factor: 6.576

3.  Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study.

Authors:  Karel Pavelká; Jindriska Gatterová; Marta Olejarová; Stanislav Machacek; Giampaolo Giacovelli; Lucio C Rovati
Journal:  Arch Intern Med       Date:  2002-10-14

4.  Associations between pain, function, and radiographic features in osteoarthritis of the knee.

Authors:  Béla Szebenyi; Anthony P Hollander; Paul Dieppe; Brian Quilty; John Duddy; Shane Clarke; John R Kirwan
Journal:  Arthritis Rheum       Date:  2006-01

5.  Effects of doxycycline on progression of osteoarthritis: results of a randomized, placebo-controlled, double-blind trial.

Authors:  Kenneth D Brandt; Steven A Mazzuca; Barry P Katz; Kathleen A Lane; Kenneth A Buckwalter; David E Yocum; Frederick Wolfe; Thomas J Schnitzer; Larry W Moreland; Susan Manzi; John D Bradley; Leena Sharma; Chester V Oddis; Steven T Hugenberg; Louis W Heck
Journal:  Arthritis Rheum       Date:  2005-07

6.  Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthritis structural arthritis study.

Authors:  Clifton O Bingham; J Chris Buckland-Wright; Patrick Garnero; Stanley B Cohen; Maxime Dougados; Silvano Adami; Daniel J Clauw; Timothy D Spector; Jean-Pierre Pelletier; Jean-Pierre Raynauld; Vibeke Strand; Lee S Simon; Joan M Meyer; Gary A Cline; John F Beary
Journal:  Arthritis Rheum       Date:  2006-11

7.  Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis.

Authors:  Daniel O Clegg; Domenic J Reda; Crystal L Harris; Marguerite A Klein; James R O'Dell; Michele M Hooper; John D Bradley; Clifton O Bingham; Michael H Weisman; Christopher G Jackson; Nancy E Lane; John J Cush; Larry W Moreland; H Ralph Schumacher; Chester V Oddis; Frederick Wolfe; Jerry A Molitor; David E Yocum; Thomas J Schnitzer; Daniel E Furst; Allen D Sawitzke; Helen Shi; Kenneth D Brandt; Roland W Moskowitz; H James Williams
Journal:  N Engl J Med       Date:  2006-02-23       Impact factor: 91.245

8.  OMERACT/OARSI initiative to define states of severity and indication for joint replacement in hip and knee osteoarthritis.

Authors:  Laure Gossec; Gillian Hawker; Aileen M Davis; Jean Francis Maillefert; L Stefan Lohmander; Roy Altman; Jolanda Cibere; Philip G Conaghan; Marc C Hochberg; Joanne M Jordan; Jeffrey N Katz; Lyn March; Nizar Mahomed; Karel Pavelka; Ewa M Roos; Maria E Suarez-Almazor; Gustavo Zanoli; Maxime Dougados
Journal:  J Rheumatol       Date:  2007-06       Impact factor: 4.666

9.  Evaluation of the structure-modifying effects of diacerein in hip osteoarthritis: ECHODIAH, a three-year, placebo-controlled trial. Evaluation of the Chondromodulating Effect of Diacerein in OA of the Hip.

Authors:  M Dougados; M Nguyen; L Berdah; B Maziéres; E Vignon; M Lequesne
Journal:  Arthritis Rheum       Date:  2001-11

10.  Association of pain with radiological changes in different compartments and views of the knee joint.

Authors:  F M Cicuttini; J Baker; D J Hart; T D Spector
Journal:  Osteoarthritis Cartilage       Date:  1996-06       Impact factor: 6.576

View more
  24 in total

1.  Preoperative pain and function profiles reflect consistent TKA patient selection among US surgeons.

Authors:  David C Ayers; Wenjun Li; Leslie Harrold; Jeroan Allison; Patricia D Franklin
Journal:  Clin Orthop Relat Res       Date:  2015-01       Impact factor: 4.176

2.  Incidence and prevalence of total joint replacements due to osteoarthritis in the elderly: risk factors and factors associated with late life prevalence in the AGES-Reykjavik Study.

Authors:  Helgi Jonsson; Sigurbjorg Olafsdottir; Solveig Sigurdardottir; Thor Aspelund; Gudny Eiriksdottir; Sigurdur Sigurdsson; Tamara B Harris; Lenore Launer; Vilmundur Gudnason
Journal:  BMC Musculoskelet Disord       Date:  2016-01-12       Impact factor: 2.362

3.  Updating the OMERACT filter: implications for imaging and soluble biomarkers.

Authors:  Maria-Antonietta D'Agostino; Maarten Boers; John Kirwan; Désirée van der Heijde; Mikkel Østergaard; Georg Schett; Robert B Landewé; Walter P Maksymowych; Esperanza Naredo; Maxime Dougados; Annamaria Iagnocco; Clifton O Bingham; Peter M Brooks; Dorcas E Beaton; Frederique Gandjbakhch; Laure Gossec; Francis Guillemin; Sarah E Hewlett; Margreet Kloppenburg; Lyn March; Philip J Mease; Ingrid Moller; Lee S Simon; Jasvinder A Singh; Vibeke Strand; Richard J Wakefield; George A Wells; Peter Tugwell; Philip G Conaghan
Journal:  J Rheumatol       Date:  2014-03-01       Impact factor: 4.666

4.  Extent of tibiofemoral osteoarthritis before knee arthroplasty: multicenter data from the osteoarthritis initiative.

Authors:  Daniel L Riddle; William A Jiranek; Robert S Neff; Derek Whitaker; Jason R Hull
Journal:  Clin Orthop Relat Res       Date:  2012-03-27       Impact factor: 4.176

5.  [Prescription frequency of physical therapy and analgesics before total hip and knee arthroplasy : An epidemiological analysis of routine health care data from Germany].

Authors:  Toni Lange; Andres Luque Ramos; Katinka Albrecht; Klaus-Peter Günther; Hannes Jacobs; Jochen Schmitt; Falk Hoffmann; Jens Goronzy; Anne Postler
Journal:  Orthopade       Date:  2018-12       Impact factor: 1.087

6.  Disability for daily living is a predictor for joint replacement in patients with end-stage knee osteoarthritis.

Authors:  Lizu Liu; Muneaki Ishijima; Haruka Kaneko; Ippei Futami; Ryo Sadatsuki; Shinnosuke Hada; Anwarjan Yusup; Yukio Shimura; Mitsuaki Kubota; Yoshitomo Saita; Yuji Takazawa; Hiroshi Ikeda; Hisashi Kurosawa; Kazuo Kaneko
Journal:  J Bone Miner Metab       Date:  2013-08-07       Impact factor: 2.626

7.  Systolic and pulse pressure associate with incident knee osteoarthritis: data from the Osteoarthritis Initiative.

Authors:  Grace H Lo; Timothy E McAlindon; Jeffrey N Katz; Jeffrey B Driban; Lori Lyn Price; Charles B Eaton; Nancy J Petersen; Christie M Ballantyne; Maria E Suarez-Almazor
Journal:  Clin Rheumatol       Date:  2017-06-01       Impact factor: 2.980

Review 8.  How to define responders in osteoarthritis.

Authors:  Cyrus Cooper; Jonathan D Adachi; Thomas Bardin; Francis Berenbaum; Bruno Flamion; Helgi Jonsson; John A Kanis; Franz Pelousse; Willem F Lems; Jean-Pierre Pelletier; Johanne Martel-Pelletier; Susanne Reiter; Jean-Yves Reginster; René Rizzoli; Olivier Bruyère
Journal:  Curr Med Res Opin       Date:  2013-04-17       Impact factor: 2.580

9.  Use of a validated algorithm to judge the appropriateness of total knee arthroplasty in the United States: a multicenter longitudinal cohort study.

Authors:  Daniel L Riddle; William A Jiranek; Curtis W Hayes
Journal:  Arthritis Rheumatol       Date:  2014-08       Impact factor: 10.995

10.  The diagnostic performance of radiography for detection of osteoarthritis-associated features compared with MRI in hip joints with chronic pain.

Authors:  Li Xu; Daichi Hayashi; Ali Guermazi; David J Hunter; Ling Li; Anton Winterstein; Klaus Bohndorf; Frank W Roemer
Journal:  Skeletal Radiol       Date:  2013-07-11       Impact factor: 2.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.